Glycemic and insulinemic response after oral ingestion of HBF2020-04
- Conditions
- Healthy Japanease adults
- Registration Number
- JPRN-UMIN000042533
- Lead Sponsor
- Oneness Support Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
[1] Who have a disease and/or surgical history of serious hepatopathy, kidney damage, gastrointestinal disease, heart disease, peripheral vascular disorder, others which may affect the results of the study. [2] Who with liver disorder, and/or kidney disorder. [5] who are under medical treatments. [6] Who are allergic to foods and/or medicines. [7] Who are diagnosed as anemia. [8] Who play intense sports and/or on a diet. [10] Who use supplements which may affect the results of the study. [11] Who take medicines. [12] Who daily take excessive alcohol, and/or can't abstinent from alcohol from the day before the each examinations. [13] Who are or are possibly pregnant, or who are lactating, during the study period. [14] Who are participating or are willing to participate in other studies. [15] Who are judged inappropriate for the study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose and insulin level at 15, 30, 45, 60, 90, 120 min after ingestion
- Secondary Outcome Measures
Name Time Method Physical examination, and medical examination by hematology, blood biochemistry, urinalysis